Elizabeth A. Whalen

Radiation Oncology
200 Kennedy Dr
Torrington, CT 06790

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma.

Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma.

Journal: Scientific reports
Published: January 27, 2021
Showing 1-1 of 1

Last Updated: 09/26/2026